Physicians Financial Services Inc. Buys Shares of 7,030 Lam Research Co. (NASDAQ:LRCX)

Physicians Financial Services Inc. bought a new position in Lam Research Co. (NASDAQ:LRCX) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 7,030 shares of the semiconductor company’s stock, valued at approximately $508,000.

Other hedge funds also recently bought and sold shares of the company. Cypress Capital Group lifted its position in Lam Research by 3.7% in the third quarter. Cypress Capital Group now owns 3,660 shares of the semiconductor company’s stock valued at $2,987,000 after purchasing an additional 132 shares during the last quarter. Savvy Advisors Inc. lifted its position in Lam Research by 58.3% in the third quarter. Savvy Advisors Inc. now owns 364 shares of the semiconductor company’s stock valued at $297,000 after purchasing an additional 134 shares during the last quarter. West Oak Capital LLC lifted its position in Lam Research by 50.9% in the fourth quarter. West Oak Capital LLC now owns 400 shares of the semiconductor company’s stock valued at $29,000 after purchasing an additional 135 shares during the last quarter. Baldwin Investment Management LLC lifted its position in Lam Research by 1.4% in the third quarter. Baldwin Investment Management LLC now owns 10,249 shares of the semiconductor company’s stock valued at $8,364,000 after purchasing an additional 137 shares during the last quarter. Finally, Bedell Frazier Investment Counselling LLC lifted its position in Lam Research by 10.1% in the third quarter. Bedell Frazier Investment Counselling LLC now owns 1,559 shares of the semiconductor company’s stock valued at $1,272,000 after purchasing an additional 143 shares during the last quarter. Institutional investors own 84.61% of the company’s stock.

Lam Research Stock Performance

Shares of NASDAQ:LRCX opened at $89.02 on Friday. Lam Research Co. has a 52 week low of $68.87 and a 52 week high of $113.00. The stock has a market capitalization of $114.27 billion, a P/E ratio of 27.04, a PEG ratio of 1.45 and a beta of 1.46. The firm has a fifty day simple moving average of $78.27 and a two-hundred day simple moving average of $77.97. The company has a quick ratio of 1.73, a current ratio of 2.54 and a debt-to-equity ratio of 0.51.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings results on Wednesday, January 29th. The semiconductor company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. Lam Research had a net margin of 26.49% and a return on equity of 51.86%. On average, analysts expect that Lam Research Co. will post 3.71 earnings per share for the current fiscal year.

Lam Research Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 9th. Investors of record on Wednesday, March 5th will be issued a dividend of $0.23 per share. The ex-dividend date is Wednesday, March 5th. This represents a $0.92 dividend on an annualized basis and a yield of 1.03%. Lam Research’s payout ratio is 27.95%.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on LRCX. Mizuho boosted their target price on Lam Research from $87.00 to $100.00 and gave the company an “outperform” rating in a research note on Thursday. Stifel Nicolaus reissued a “buy” rating and set a $100.00 target price (down from $105.00) on shares of Lam Research in a research note on Thursday, October 24th. Wolfe Research cut Lam Research from an “outperform” rating to a “peer perform” rating in a research note on Wednesday, January 15th. The Goldman Sachs Group reduced their price target on Lam Research from $96.00 to $85.00 and set a “buy” rating on the stock in a research note on Friday, January 10th. Finally, Susquehanna raised Lam Research from a “neutral” rating to a “positive” rating and upped their price target for the stock from $75.00 to $125.00 in a research note on Thursday. Six investment analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $98.22.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.